R-Bio
TX - HoustonBiotechnology
Focus: R-Bio is a Houston-based biotechnology company specializing in biosimilar production and regenerative medicine, with a focus on cell therapy and oncology applications. The company operates at an early-stage biotech scale with limited public financial disclosure.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Open Jobs
0
About R-Bio
AI assessmentNot HiringNo open roles listed right now. Follow R-Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Autologous Adipose Tissue derived MSCs Transplantation
Avascular Necrosis of the Femoral HeadAutologous Adipose Tissue derived MSCs Transplantation
Progressive Hemifacial AtrophyHelp build intelligence for R-Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.